These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 750805)
1. The Food and Drug Administration and freedom of information. Radzius JR Leg Aspects Med Pract; 1978 Jan; 6(1):52-4. PubMed ID: 750805 [No Abstract] [Full Text] [Related]
2. Personal responsibility and the Food and Drug Law. Janssen WF FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122 [No Abstract] [Full Text] [Related]
3. RU 486 and the politics of drug regulation in the United States and France. Kramnick RK Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340 [No Abstract] [Full Text] [Related]
4. Progress under the Kefauver-Harris Drug Amendments. Rankin WB Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717 [No Abstract] [Full Text] [Related]
5. Therapeutic freedom. Trout ME J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704 [No Abstract] [Full Text] [Related]
6. Labeling regulations: 'prescribe as directed'. Regier H J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706 [No Abstract] [Full Text] [Related]
7. [Problems connected with the drug provision in the United States]. Sloot HA Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761 [No Abstract] [Full Text] [Related]
8. Fifty years of drug amendments revisited: in easy-to-swallow capsule form. Kaplan AH Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042 [No Abstract] [Full Text] [Related]
9. [Legislation concerning specialties and pharmaceutical specialty explained by various examples]. Escher A Pharm Acta Helv; 1966 Dec; 41(12):641-57. PubMed ID: 6013638 [No Abstract] [Full Text] [Related]
10. Implications of the Lannett and Pharmadyne decisions. Vetrano AJ Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217 [TBL] [Abstract][Full Text] [Related]
12. Drug information resources for health professionals and consumers. Durkin C Natl Netw; 1998 Feb; 22(3):10-1. PubMed ID: 10176590 [No Abstract] [Full Text] [Related]
13. Section 8(c) of the proposed Restatement (Third) of Torts: is it really what the doctor ordered? Winchester JD Cornell Law Rev; 1997 Mar; 82(3):644-93. PubMed ID: 10343053 [No Abstract] [Full Text] [Related]
14. Communication for child mental health: 1973 NIMH information interchange. Health Serv Rep; 1973 May; 88(5):391-9. PubMed ID: 4350572 [No Abstract] [Full Text] [Related]
15. Food and Drug Administration. Tempest over polio vaccine. Anderson C Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758 [No Abstract] [Full Text] [Related]
16. Confronting a new obstacle to reproductive choice: encouraging the development of RU-486 through reform of products liability law. Rubin LA Rev Law Soc Change; 1990-1991; 18(1):131-59. PubMed ID: 11656168 [No Abstract] [Full Text] [Related]
18. FDA tightens rules on advertising. Josefson D BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658 [No Abstract] [Full Text] [Related]
19. PMA suit addresses the real issue. J Indiana State Med Assoc; 1979 Mar; 72(3):163. PubMed ID: 422861 [No Abstract] [Full Text] [Related]
20. View from the Nation's Capital. FDA challenged successfully on its policies regarding good manufacturing practice inspections of medical drug and device manufacturers. Appler WD J Clin Psychopharmacol; 1987 Oct; 7(5):346-7. PubMed ID: 3680606 [No Abstract] [Full Text] [Related] [Next] [New Search]